Aspirin on Top of Anticoagulation in Patients With Concomitant Stable Coronary Artery Disease and Atrial Fibrillation

Affiliations

¹ USIC et Centre Hémodynamique, Institut Coeur Poumon, Centre Hospitalier Universitaire de Lille, France. Faculté de Médecine de l'Université de Lille, France. INSERM UMR 1011, Institut Pasteur de Lille, France. FACT (French Alliance for Cardiovascular Trials), Paris, France.

Editorial

Gilles Lemesle. Circulation. 2019.

. 2019 Jan 29;139(5):617-619.

doi: 10.1161/CIRCULATIONAHA.118.037440.

¹ USIC et Centre Hémodynamique, Institut Coeur Poumon, Centre Hospitalier Universitaire de Lille, France. Faculté de Médecine de l'Université de Lille, France. INSERM UMR 1011, Institut Pasteur de Lille, France. FACT (French Alliance for Cardiovascular Trials), Paris, France.

No abstract available

Keywords: Editorials; anticoagulants; antiplatelet agents; atrial fibrillation; coronary artery disease.

Comment on

Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.
Matsumura-Nakano Y, Shizuta S, Komasa A, Morimoto T, Masuda H, Shiomi H, Goto K, Nakai K, Ogawa H, Kobori A, Kono Y, Kaitani K, Suwa S, Aoyama T, Takahashi M, Sasaki Y, Onishi Y, Mano T, Matsuda M, Motooka M, Tomita H, Inoko M, Wakeyama T, Hagiwara N, Tanabe K, Akao M, Miyauchi K, Yajima J, Hanaoka K, Morino Y, Ando K, Furukawa Y, Nakagawa Y, Nakao K, Kozuma K, Kadota K, Kimura K, Kawai K, Ueno T, Okumura K, Kimura T; OAC-ALONE Study Investigators. Matsumura-Nakano Y, et al. Circulation. 2019 Jan 29;139(5):604-616. doi: 10.1161/CIRCULATIONAHA.118.036768. Circulation. 2019. PMID: 30586700 Clinical Trial.